Molecular Biomarkers in Cancer will be presented by Scott Dessain, MD, Lankenau Institute for Medical Research, Wynnewood, PA.
MBoC is an educational initiative sponsored by Genentech BioOncology to provide a synopsis of fundamental and evolving concepts on key molecular biomarkers currently impacting the diagnosis and treatment of cancer.
This presentation includes:
-A historical perspective on prognostic and predictive biomarkers in cancer
-A review of biomarkers currently used in screening, diagnosis, disease monitoring, and drugresponse/resistance
-Details on advanced molecular techniques helpful in the detection and analysis of biomarkers
-Discussion of major challenges faced during conception, validation, and use of cancer biomarkers
-Tumor type profiling exercises that review the detection and use of biomarkers in clinical practice
Register online at www.genersvp.com.
Please note that this a non-promotional, industry sponsored event and is NOT accredited for CME.